1. Home
  2. VNDA vs FMAO Comparison

VNDA vs FMAO Comparison

Compare VNDA & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • FMAO
  • Stock Information
  • Founded
  • VNDA 2002
  • FMAO 1897
  • Country
  • VNDA United States
  • FMAO United States
  • Employees
  • VNDA N/A
  • FMAO 467
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • FMAO Savings Institutions
  • Sector
  • VNDA Health Care
  • FMAO Finance
  • Exchange
  • VNDA Nasdaq
  • FMAO Nasdaq
  • Market Cap
  • VNDA 270.2M
  • FMAO 372.5M
  • IPO Year
  • VNDA 2006
  • FMAO N/A
  • Fundamental
  • Price
  • VNDA $4.73
  • FMAO $27.23
  • Analyst Decision
  • VNDA Buy
  • FMAO Hold
  • Analyst Count
  • VNDA 1
  • FMAO 2
  • Target Price
  • VNDA $13.00
  • FMAO $26.00
  • AVG Volume (30 Days)
  • VNDA 641.3K
  • FMAO 17.9K
  • Earning Date
  • VNDA 11-06-2024
  • FMAO 10-28-2024
  • Dividend Yield
  • VNDA N/A
  • FMAO 3.26%
  • EPS Growth
  • VNDA N/A
  • FMAO N/A
  • EPS
  • VNDA N/A
  • FMAO 1.56
  • Revenue
  • VNDA $182,022,000.00
  • FMAO $95,411,000.00
  • Revenue This Year
  • VNDA $6.70
  • FMAO N/A
  • Revenue Next Year
  • VNDA $51.03
  • FMAO $7.89
  • P/E Ratio
  • VNDA N/A
  • FMAO $17.42
  • Revenue Growth
  • VNDA N/A
  • FMAO N/A
  • 52 Week Low
  • VNDA $3.30
  • FMAO $16.90
  • 52 Week High
  • VNDA $6.75
  • FMAO $28.76
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 48.57
  • FMAO 50.88
  • Support Level
  • VNDA $4.68
  • FMAO $25.93
  • Resistance Level
  • VNDA $4.98
  • FMAO $28.76
  • Average True Range (ATR)
  • VNDA 0.18
  • FMAO 0.64
  • MACD
  • VNDA 0.05
  • FMAO 0.05
  • Stochastic Oscillator
  • VNDA 40.00
  • FMAO 52.19

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About FMAO Farmers & Merchants Bancorp Inc.

Farmers & Merchants Bancorp Inc is a holding company for Farmers & Merchants Bank of Central California. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.

Share on Social Networks: